Efficacy of Anti-TNF Agents as Adjunctive Therapy for Knee Synovitis Refractory to Disease-Modifying Antirheumatic Drugs in Patients with Peripheral Spondyloarthritis.

about

Efficacy of Anti-TNF Agents as Adjunctive Therapy for Knee Synovitis Refractory to Disease-Modifying Antirheumatic Drugs in Patients with Peripheral Spondyloarthritis.

Item

http://www.wikidata.org/entity/Q43115288

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Efficacy of Anti-TNF Agents as ...... Peripheral Spondyloarthritis.

@en

Efficacy of Anti-TNF Agents as ...... Peripheral Spondyloarthritis.

@nl

type

Item

label

Efficacy of Anti-TNF Agents as ...... Peripheral Spondyloarthritis.

@en

Efficacy of Anti-TNF Agents as ...... Peripheral Spondyloarthritis.

@nl

prefLabel

Efficacy of Anti-TNF Agents as ...... Peripheral Spondyloarthritis.

@en

Efficacy of Anti-TNF Agents as ...... Peripheral Spondyloarthritis.

@nl

P1476

Efficacy of Anti-TNF Agents as ...... Peripheral Spondyloarthritis.

@en

P2093

Anastasios Gketsos

http://www.w3.org/2001/XMLSchema#string

Athanasios D Anastasilakis

http://www.w3.org/2001/XMLSchema#string

Charalampos Berberidis

http://www.w3.org/2001/XMLSchema#string

Grigorios T Sakellariou

http://www.w3.org/2001/XMLSchema#string

Ilias Bisbinas

http://www.w3.org/2001/XMLSchema#string

P2860

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.

Psoriatic arthritis: epidemiology, clinical features, course, and outcome.

Predictors for radiological damage in psoriatic arthritis: results from a single centre.

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis.

Predictors of outcome in patients with oligoarthritis: results of a protocol of intraarticular corticosteroids to all clinically active joints.

Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.

P304

907085

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/907085

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248386128

http://www.w3.org/2001/XMLSchema#string

P698

23840963

http://www.w3.org/2001/XMLSchema#string

P921

TNF inhibitor

P932

3693177

http://www.w3.org/2001/XMLSchema#string